Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

NCT06632327 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1100

Enrollment

OTHER

Sponsor class

Conditions

Resectable Lung Non-Small Cell Carcinoma
Stage II Lung Cancer AJCC v8
Stage IIIA Lung Cancer AJCC v8
Stage IIIB Lung Cancer AJCC v8

Interventions

PROCEDURE: Surgical Procedure
DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Pemetrexed
DRUG: Gemcitabine
DRUG: Docetaxel
DRUG: Vinorelbine
DRUG: Nivolumab
DRUG: Pembrolizumab
DRUG: Atezolizumab
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]